Quay lại

Published Date: 29/04/2025

  • Long Chau continues to be a bright spot for FRT, with its leading position in the pharmaceutical retail market. The pharmacy chain continues to expand in
    scale and optimize cost efficiency in the FY25-FY26
  • We estimate net profit (NP) in 2025-26 to increase by 111%/36% yoy, reaching 670/939 VNDbn, with the main driver comes from Long Chau.
  • We recommend ADD with a target price of 202,400 VND/share.
FRT - Update - Long Chau maintains robust growth momentum
© Copyrights 2000 - 2021 MBS, a member of MB Group
Về đầu trang